Skip to main content
Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
128.96
+0.93 (0.73%)
At close: Dec 5, 2025, 4:00 PM EST
129.22
+0.26 (0.20%)
After-hours: Dec 5, 2025, 7:55 PM EST

Illumina Revenue

Illumina had revenue of $1.08B in the quarter ending September 28, 2025, with 0.37% growth. This brings the company's revenue in the last twelve months to $4.29B, down -2.32% year-over-year. In the year 2024, Illumina had annual revenue of $4.37B, down -2.93%.

Revenue (ttm)
$4.29B
Revenue Growth
-2.32%
P/S Ratio
4.71
Revenue / Employee
$413,500
Employees
10,370
Market Cap
19.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 29, 20244.37B-132.00M-2.93%
Dec 31, 20234.50B-80.00M-1.75%
Jan 1, 20234.58B58.00M1.28%
Jan 2, 20224.53B1.29B39.73%
Jan 3, 20213.24B-304.00M-8.58%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Jan 1, 2017 Pro Pro Pro
Jan 3, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

ILMN News

More News